[1] SKULACHEV V P. Cationic antioxidants as a powerful tool against mitochondrial oxidative stress[J]. Biochemical and biophysical research communications, 2013, 441 2: Pages 275-279. DOI:
10.1016/j.bbrc.2013.10.063[2] N. STEFANOVA. An antioxidant specifically targeting mitochondria delays progression of Alzheimer’s disease-like pathology[J]. Aging (Albany NY), 2016, 41 1: 2713-2731. DOI:
10.18632/aging.101054[3] ALEXANDER A ANDREEV-ANDRIEVSKIY. Efficacy of Mitochondrial Antioxidant Plastoquinonyl-decyl-triphenylphosphonium Bromide (SkQ1) in the Rat Model of Autoimmune Arthritis.[J]. Oxidative Medicine and Cellular Longevity, 2016: 8703645. DOI:
10.1155/2016/8703645[4] M. V. SKULACHEV V. P S F F Severin. Receptor regulation of senile phenoptosis[J]. Biochemistry (Moscow), 2014, 79 10: 994-1003. DOI:
10.1134/s0006297914100022[5] E.Y. PLOTNIKOV. Mechanisms of nephroprotective effect of mitochondria-targeted antioxidants under rhabdomyolysis and ischemia/reperfusion[J]. Biochimica et biophysica acta. Molecular basis of disease, 2011, 1812 1: Pages 77-86. DOI:
10.1016/j.bbadis.2010.09.008[6] EGOR Y PLOTNIKOV. Protective effect of mitochondria-targeted antioxidants in an acute bacterial infection.[J]. Proceedings of the National Academy of Sciences of the United States of America, 2013, 110 33: E3100-8. DOI:
10.1073/pnas.1307096110[7] VLADIMIR P. SKULACHEV . An attempt to prevent senescence: A mitochondrial approach[J]. Biochimica et Biophysica Acta-Bioenergetics, 2009, 1787 5: Pages 437-461. DOI:
10.1016/j.bbabio.2008.12.008 
